Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Andersen

Showing results (531-540 of 547) with videos related to

Pageof 55
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Journal of Epidemiology and Community Health|May 15, 2004
Socioeconomic inequalities in mortality among elderly people in 11 European populationsM Huisman, A E Kunst, O Andersen, et al.
Journal of the Air & Waste Management Association (1995)|December 19, 2013
Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy storyA Gwen Eklund, Samuel L Altshuler, Paulina C Altshuler, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 7, 2023
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart studyMaarten Z H Kolk, Diana M Frodi, Joss Langford, et al.
Brain : a Journal of Neurology|January 20, 2007
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASILW C Low, M Junna, A Börjesson-Hanson, et al.
European Journal of Neurology|October 16, 2020
Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosisM Biström, D Jons, E Engdahl, et al.
Journal of Internal Medicine|June 22, 2010
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJ Eugen-Olsen, O Andersen, A Linneberg, et al.
American Journal of Public Health|February 13, 1999
Occupational class and ischemic heart disease mortality in the United States and 11 European countriesA E Kunst, F Groenhof, O Andersen, et al.
Genes and Immunity|July 26, 2002
A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosisE Akesson, A Oturai, J Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Pageof 55

Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Journal of Epidemiology and Community Health|May 15, 2004
Socioeconomic inequalities in mortality among elderly people in 11 European populationsM Huisman, A E Kunst, O Andersen, et al.
Journal of the Air & Waste Management Association (1995)|December 19, 2013
Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy storyA Gwen Eklund, Samuel L Altshuler, Paulina C Altshuler, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 7, 2023
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart studyMaarten Z H Kolk, Diana M Frodi, Joss Langford, et al.
Brain : a Journal of Neurology|January 20, 2007
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASILW C Low, M Junna, A Börjesson-Hanson, et al.
European Journal of Neurology|October 16, 2020
Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosisM Biström, D Jons, E Engdahl, et al.
Journal of Internal Medicine|June 22, 2010
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJ Eugen-Olsen, O Andersen, A Linneberg, et al.
American Journal of Public Health|February 13, 1999
Occupational class and ischemic heart disease mortality in the United States and 11 European countriesA E Kunst, F Groenhof, O Andersen, et al.
Genes and Immunity|July 26, 2002
A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosisE Akesson, A Oturai, J Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosisN Mattsson, M Axelsson, S Haghighi, et al.
Pageof 55